Impact of Initial Axillary Microaxial Flow Pump on Post-Myocardial Infarction Ventricular Septal Defect Management
Interdisciplinary CardioVascular and Thoracic Surgery · 2025
DOI: 10.1093/icvts/ivaf253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, 2025. Verfasst von Kenta Murakami und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Engineering, Nagoya Tokushukai General Hospital, Kasugai Aichi 487-0016, Japan. Hauptthemen laut MEDLINE: Myocardial Infarction, Heart-Assist Devices, Heart Septal Defects, Ventricular. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
The mortality rate of ventricular septal defect (VSD) following acute myocardial infarction remains high. Mechanical circulatory support devices have been shown to facilitate delayed surgery and improve postoperative survival, although clear guidelines for device selection are lacking.
Methods
This study presents a retrospective cohort analysis of 18 patients with post-infarction VSD treated with microaxial flow pump (mAFP) from March 2017 to November 2024. Patients were divided into 2 groups: the percutaneous group utilized Impella 2.5 or CP (Abiomed, Danvers, MA, USA) and the axillary access group (Impella 5.0 or 5.5). Their clinical outcomes and early to midterm survival rates were analysed.
Results
The survival discharge rate was 31% (4 in 13 patients) in the percutaneous group and 100% (5 patients) in the axillary access group, with a significant difference (P = .029). Seven patients who were initially managed with percutaneous mAFP and later required the addition of extracorporeal membrane oxygenation all died perioperatively. The 100-day Kaplan-Meier analysis showed a significant improvement in survival rates in the axillary access group compared to the percutaneous group (log-rank, P = .020).
Conclusions
These findings illustrate variation in surgical timing and device selection and suggest that the early use of an axillary access mAFP may warrant further investigation in post-myocardial infarction VSD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Engineering, Nagoya Tokushukai General Hospital, Kasugai Aichi 487-0016, Japan.
- Department of Cardiology, Nagoya Tokushukai General Hospital, Kasugai Aichi 487-0016, Japan.
- Department of Cardiovascular Surgery, Nagoya Tokushukai General Hospital, Kasugai Aichi 487-0016, Japan.
ORCID-Profile: Kenta Murakami, Shin Hasegawa, Akimitsu Tanaka
Zitieren
APA
Murakami, K., Hasegawa, S., Miki, A., Yamauchi, H., Tanaka, A., Ohashi, T., & Hosoba, S. (2025). Impact of Initial Axillary Microaxial Flow Pump on Post-Myocardial Infarction Ventricular Septal Defect Management. Interdisciplinary CardioVascular and Thoracic Surgery. https://doi.org/10.1093/icvts/ivaf253
Vancouver
Murakami K, Hasegawa S, Miki A, Yamauchi H, Tanaka A, Ohashi T, et al. Impact of Initial Axillary Microaxial Flow Pump on Post-Myocardial Infarction Ventricular Septal Defect Management. Interdisciplinary CardioVascular and Thoracic Surgery. 2025. doi:10.1093/icvts/ivaf253
BibTeX
@article{Murakami2025,
author = {Murakami, Kenta and Hasegawa, Shin and Miki, Akinao and Yamauchi, Hirotaka and Tanaka, Akimitsu and Ohashi, Takeki and Hosoba, Soh},
title = {Impact of Initial Axillary Microaxial Flow Pump on Post-Myocardial Infarction Ventricular Septal Defect Management},
journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
year = {2025},
doi = {10.1093/icvts/ivaf253}
}
EUVIMED